Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI

Journal of Biomedical Materials Research - Part A

Volumn 78, Issue 3, 2006, Pages 550-557

  Sun, Conroy ^a   Sze, Raymond ^b   Zhang, Miqin ^a,b  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cellular targeting; Folic acid; MRI; Nanoparticle

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID (FA); INDUCTIVELY COUPLED PLASMA SPECTROSCOPY; NANOPARTICLES;

BIOASSAY; CELLS; HYDROGEN BONDS; INDUCTIVELY COUPLED PLASMA; IRON OXIDES; MAGNETIC RESONANCE IMAGING; POLYETHYLENE GLYCOLS; SUPERPARAMAGNETISM; TUMORS;

NANOSTRUCTURED MATERIALS;

AMIDE; DEXTRAN; FOLATE RECEPTOR; FOLIC ACID; FUNCTIONAL GROUP; MACROGOL; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER DIAGNOSIS; CELL STRAIN MG 63; CELL TRANSPORT; COMPETITIVE INHIBITION; CONJUGATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; COVALENT BOND; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; MAGNETISM; MASS SPECTROMETRY; MATERIAL COATING; MOLECULAR STABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA CELL; SUPERPARAMAGNETIC NANOPARTICLE; TARGET CELL;

DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; FOLIC ACID; HELA CELLS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; NANOSTRUCTURES; POLYETHYLENE GLYCOLS;

EID: 33747441837     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30781     Document Type: Article

References (36)

1. Josephson L, Lewis J, Jacobs P, Hahn PF, Stark DD. The effects of iron-oxides on proton relaxivity. Magn Reson Imaging 1988; 6:647-653.
2. Cheng FY, Su CH, Yang YS, Yeh CS, Tsai CY, Wu CL, Wu MT, Shieh DB. Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications. Biomaterials 2005;26:729-738.
3. Tartaj P, Morales MD, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ. The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 2003;36:R182-R197.
4. Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005;26:3995-4021.
5. Jun YW, Huh YM, Choi JS, Lee JH, Song HT, Kim S, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. J Am Chem Soc 2005;127: 5732-5733.
6. Wang YXJ, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319-2331.
7. Weissleder R, Stark DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J. Superparamagnetic iron-oxide-Pharmacokinetics and toxicity. Am J Roentgenol 1989; 152(1):167-173.
8. Weissleder R, Bogdanov A, Papisov M. Drug targeting in magnetic resonance imaging. Magn Reson Q 1992;8(1):55-63.
9. Veiseh O, Sun C, Gunn J, Kohler N, Gabikian P, Lee D, Bhattarai N, Ellenbogen R, Sze R, Hallahan A, Olson J, Zhang M. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005;5:1003-1008.
10. Huh YM, Jun YW, Song HT, Kim S, Choi JS, Lee JH, Yoon S, Kim KS, Shin JS, Suh JS, Cheon J. In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. J Am Chem Soc 2005;127:12387-12391.
11. Cerdan S, Lotscher HR, Kunnecke B, Seelig J. Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn Reson Med 1989; 12(2):151-163.
12. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH, Deleij L. Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 1992;25(1):148-157.
13. Weissleder R, Lee AS, Fischman AJ, Reimer P, Shen T, Wilkinson R, Callahan RJ, Brady TJ. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: Antibody MR imaging. Radiology 1991;181(1):245-249.
14. Tiefenauer LX, Kuhne G, Andres RY. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjug Chem 1993;4:347-352.
15. Kresse M, Wagner S, Pfefferer D, Lawaczeck R, Elste V, Semmler W. Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in vivo by using transferrin receptor pathways. Magn Reson Med 1998;40:236-242.
16. Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem 2002;13:264-268.
17. Jain RK. Transport of molecules in the tumor interstitium-A review. Cancer Res 1987;47:3039-3051.
18. McNeil SE. Nanotechnology for the biologist. J Leukoc Biol 2005;78:585-594.
19. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989;6:193-210.
20. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr, Kamen BA. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 1992;52:3396-3401.
21. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994;73:2432-2443.
22. Park EK, Lee SB, Lee YM. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005;26:1053-1061.
23. Leamon CP, Low PS. Delivery of macromolecules into living cells: A method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 1991;88:5572-5576.
24. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 1994;269: 3198-3204.
25. Gruner BA, Weitman SD. The folate receptor as a potential therapeutic anticancer target. Invest New Drugs 1998;16:205-219.
26. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000;41(2):147-162.
27. Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst 1998;15:587-627.
28. Zhang Y, Kohler N, Zhang MQ. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002;23:1553-1561.
29. Zhang Y, Sun C, Kohler N, Zhang MQ. Self-assembled coatings on individual monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomed Microdevices 2004;6(1):33-40.
30. Zhang MQ, Desai T, Ferrari M. Proteins and cells on PEG immobilized silicon surfaces. Biomaterials 1998,19:953-960.
31. Butterworth MD, Illum L, Davis SS. Preparation of ultrafine silica- and PEG-coated magnetite particles. Colloids Surf A Physicochem Eng Aspects 2001;179(1):93-102.
32. Kohler N, Fryxell GE, Zhang MQ. A bifunctional polyethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004;126:7206-7211.
33. Molday RS, Mackenzie D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 1982;52:353-367.
34. Dube D, Francis M, Leroux JC, Winnik FM. Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates. Bioconjug Chem 2002;13:685-692.
35. Zheng X, Kelley K, Elnakat H, Yan W, Dorn T, Ratnam M. mRNA instability in the nucleus due to a novel open reading frame element is a major determinant of the narrow tissue specificity of folate receptor alpha. Mol Cell Biol 2003;23:2202-2212.
36. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24:1001-1011.